$108.09
1.02[0.95%]
At close: Apr 23
$108.09
0[0.00%]
After Hours: 5:22PM EDT
Abbott Laboratories reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Abbott Laboratories using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
07/18/2024 | AM | ABT | Q2 | $1.08 | — | — | — | $9.98B | — | — | — | Get Alert |
04/17/2024 | AM | ABT | Q1 | $1.03 | $0.95 | $0.98 | 3.16% | $9.75B | $9.88B | $9.96B | 0.85% | Get Alert |
01/24/2024 | AM | ABT | Q4 | $1.03 | $1.19 | $1.19 | 0.00% | $10.09B | $10.18B | $10.24B | 0.60% | Get Alert |
10/18/2023 | AM | ABT | Q3 | $1.15 | $1.04 | $1.14 | 9.62% | $10.41B | $9.32B | $10.14B | 8.83% | Get Alert |
07/20/2023 | AM | ABT | Q2 | $1.43 | $1.05 | $1.08 | 2.86% | $11.26B | $9.70B | $9.98B | 2.87% | Get Alert |
04/19/2023 | AM | ABT | Q1 | $1.73 | $0.99 | $1.03 | 4.04% | $11.89B | $9.64B | $9.75B | 1.11% | Get Alert |
01/25/2023 | AM | ABT | Q4 | $1.32 | $0.92 | $1.03 | 11.96% | $11.47B | $9.64B | $10.09B | 4.68% | Get Alert |
10/19/2022 | AM | ABT | Q3 | $1.40 | $0.94 | $1.15 | 22.34% | $10.93B | $9.64B | $10.41B | 7.99% | Get Alert |
07/20/2022 | AM | ABT | Q2 | $1.17 | $1.12 | $1.43 | 27.68% | $10.22B | $10.29B | $11.26B | 9.40% | Get Alert |
04/20/2022 | AM | ABT | Q1 | $1.32 | $1.47 | $1.73 | 17.69% | $10.46B | $11.02B | $11.89B | 7.94% | Get Alert |
01/26/2022 | AM | ABT | Q4 | $1.45 | $1.21 | $1.32 | 9.09% | $10.70B | $10.71B | $11.47B | 7.08% | Get Alert |
10/20/2021 | AM | ABT | Q3 | $0.98 | $0.94 | $1.40 | 48.94% | $8.85B | $9.54B | $10.93B | 14.55% | Get Alert |
07/22/2021 | AM | ABT | Q2 | $0.57 | $1.02 | $1.17 | 14.71% | $7.33B | $9.69B | $10.22B | 5.50% | Get Alert |
04/20/2021 | AM | ABT | Q1 | $0.65 | $1.27 | $1.32 | 3.94% | $7.73B | $10.69B | $10.46B | -2.19% | Get Alert |
01/27/2021 | AM | ABT | Q4 | $0.95 | $1.35 | $1.45 | 7.41% | $8.31B | $9.94B | $10.70B | 7.66% | Get Alert |
10/21/2020 | AM | ABT | Q3 | $0.84 | $0.90 | $0.98 | 8.89% | $8.08B | $8.51B | $8.85B | 4.03% | Get Alert |
07/16/2020 | AM | ABT | Q2 | $0.82 | $0.41 | $0.57 | 39.02% | $7.98B | $6.75B | $7.33B | 8.56% | Get Alert |
04/16/2020 | AM | ABT | Q1 | $0.63 | $0.58 | $0.65 | 12.07% | $7.54B | $7.34B | $7.73B | 5.26% | Get Alert |
01/22/2020 | AM | ABT | Q4 | $0.81 | $0.95 | $0.95 | 0.00% | $7.76B | $8.26B | $8.31B | 0.65% | Get Alert |
Abbott Laboratories (ABT) is scheduled to report earnings on July 18, 2024. The last reported earnings were for reported on April 17, 2024 for Q1.
The Actual EPS was $0.98, which beat the estimate of $0.95.
The Actual Revenue was $10B, which beat the estimate of $9.9B.
Browse earnings estimates, EPS, and revenue on all stocks.